- Home
- LRMR vs KOD Comparison
LRMR vs KOD Comparison
Compare LRMR & KOD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LRMR
- KOD
- Stock Information
- Founded
- LRMR N/A
- KOD 2009
- Country
- LRMR United States
- KOD United States
- Employees
- LRMR N/A
- KOD N/A
- Industry
- LRMR Biotechnology: Pharmaceutical Preparations
- KOD Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- LRMR Health Care
- KOD Health Care
- Exchange
- LRMR Nasdaq
- KOD Nasdaq
- Market Cap
- LRMR 183.8M
- KOD 191.6M
- IPO Year
- LRMR N/A
- KOD 2018
- Fundamental
- Price
- LRMR $2.20
- KOD $2.67
- Analyst Decision
- LRMR Strong Buy
- KOD Hold
- Analyst Count
- LRMR 10
- KOD 4
- Target Price
- LRMR $19.60
- KOD $8.00
- AVG Volume (30 Days)
- LRMR 919.2K
- KOD 361.7K
- Earning Date
- LRMR 05-08-2025
- KOD 03-27-2025
- Dividend Yield
- LRMR N/A
- KOD N/A
- EPS Growth
- LRMR N/A
- KOD N/A
- EPS
- LRMR N/A
- KOD N/A
- Revenue
- LRMR N/A
- KOD N/A
- Revenue This Year
- LRMR N/A
- KOD N/A
- Revenue Next Year
- LRMR N/A
- KOD N/A
- P/E Ratio
- LRMR N/A
- KOD N/A
- Revenue Growth
- LRMR N/A
- KOD N/A
- 52 Week Low
- LRMR $1.93
- KOD $2.19
- 52 Week High
- LRMR $11.20
- KOD $11.60
- Technical
- Relative Strength Index (RSI)
- LRMR 37.86
- KOD 30.00
- Support Level
- LRMR $2.19
- KOD $2.97
- Resistance Level
- LRMR $2.44
- KOD $2.86
- Average True Range (ATR)
- LRMR 0.18
- KOD 0.26
- MACD
- LRMR -0.01
- KOD 0.02
- Stochastic Oscillator
- LRMR 35.06
- KOD 15.57
Stock Price Comparison Chart: LRMR vs KOD
About LRMR Larimar Therapeutics Inc.
Larimar Therapeutics Inc is a clinical-stage biotechnology company focused on developing treatments for patients suffering from complex rare diseases using novel cell-penetrating peptide technology platform. Its lead product candidate, CTI-1601, is a subcutaneously administered, recombinant fusion protein intended to deliver human frataxin (FXN) an essential protein, to the mitochondria of patients with Friedreich's ataxia.
About KOD Kodiak Sciences Inc
Kodiak Sciences Inc is a biopharmaceutical company specializing in novel therapeutics to treat high-prevalence retinal diseases. The product candidate of the company is KSI-301, which is a novel antibody biopolymer conjugate, in treatment-naive subjects with neovascular wet AMD.